Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

Clinical trial NCT02691130 · COMPLETED

Trial details

NCT number: NCT02691130
Sponsor: BiondVax Pharmaceuticals ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Healthy

Start date: 2015-11-01
Primary completion: 2016-10-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.